Biotech · Private company
ChromaDex, Inc.
Track this companyFree. Adds ChromaDex, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Niagen®PlusPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- 1000 mg/day of TRU NIAGEN (nicotinamide riboside)Cognitive FunctionClinicalTrials.gov · fetched Nov 12, 2026
- 300 mg/day of TRU NIAGEN (nicotinamide riboside)Cognitive FunctionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm InfantsPHASE2_PHASE3 · RECRUITING · started Aug 19, 2026ClinicalTrials.gov NCT04614714 · fetched Nov 12, 2026
- Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® PlusPHASE1 · RECRUITING · started Oct 1, 2025ClinicalTrials.gov NCT07251608 · fetched Nov 12, 2026
- Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+NA · RECRUITING · started Oct 31, 2024ClinicalTrials.gov NCT06919328 · fetched Nov 12, 2026
- NR in Chemo-induced Peripheral NeuropathyPHASE2 · TERMINATED · started Nov 8, 2019ClinicalTrials.gov NCT03642990 · fetched Nov 12, 2026
- A Study by ChromaDex to Assess the Effects of TRU NIAGEN on Cognitive Function, Mood and Sleep in Older AdultsNA · COMPLETED · started Jun 13, 2018ClinicalTrials.gov NCT03562468 · fetched Nov 12, 2026